Oppenheimer lowered the firm’s price target on Salesforce (CRM) to $250 from $275 and keeps an Outperform rating on the shares. The firm notes Salesforce’s Q4 results were decent, but missed constant currency expectations. Positively, Agentforce continues showing robust growth, increasing financials transparency, and support Salesforce’s place in the agentic future. Additionally, business reacceleration in the second half of 2027 remains intact, which is the high-end of guidance from October, and medium-term guidance is rising from Informatica outperforming and better predictability. Negatively, the beat magnitudes are smaller in Q4 and organic growth is sub-10%, Oppenheimer adds.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRM:
- Salesforce price target lowered to $281 from $330 at Goldman Sachs
- Salesforce price target lowered to $250 from $300 at Stifel
- Salesforce price target lowered to $255 from $260 at BTIG
- Salesforce price target lowered to $194 from $223 at Bernstein
- Salesforce price target lowered to $320 from $365 at JPMorgan
